Kymera | Investor Presentation Deck | 46 slides · page 25 of 46
The slide uses a process flow diagram to illustrate the transition from dose escalation (DL1-DLx) to expansion cohorts for specific indications.
Pitch deck · appendix_methodology · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 disclaimer 1/1 table 1/1 title 1/1
Components 4
process disclaimer data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1